Molecular Partners AG (MOLN) Financials

MOLN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 109.1 million 23.9 million
Dec. 31, 2025 128.7 million 27.4 million
Sept. 30, 2025 140.8 million 20.9 million
June 30, 2025 156.7 million 22.2 million

MOLN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -18.1 million 1.2 million
Dec. 31, 2025 -17.2 million 1.2 million
Sept. 30, 2025 -16.1 million 1.4 million
June 30, 2025 -16.6 million 1.5 million

MOLN Net Income

No data available :(

MOLN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 98.0 million - 4.2 million
Dec. 31, 2025 117.3 million - 4.6 million
Sept. 30, 2025 131.2 million - 1.9 million
June 30, 2025 144.4 million - 2.3 million

MOLN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 46.8 million
Dec. 31, 2025 47.2 million
Sept. 30, 2025 47.0 million
June 30, 2025 47.2 million

MOLN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 15.0 million 5.6 million -
Dec. 31, 2025 219840 14.6 million 4.6 million -
Sept. 30, 2025 79264 13.1 million 4.8 million -
June 30, 2025 121080 16.3 million 5.2 million -

MOLN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 798141
Dec. 31, 2025 - 809005
Sept. 30, 2025 - 826926
June 30, 2025 - 843508

MOLN

Price: $4

52 week price:
3.41
5.36

Earnings Per Share: -1.98 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Switzerland

Volume: 4126

Market Capitalization: 149.9 million

Links: